About 24 mn people over age 60 yet to receive first Covid jab in China

The vaccination figure fell to "just 42.4 per cent for those aged 80 and over"

vaccine
Representative Image
IANS Hong Kong
2 min read Last Updated : Dec 26 2022 | 12:32 PM IST

Nearly 23.8 million people over the age of 60 in China are yet to receive their first shot of Covid-19 vaccine as the country goes through a massive surge in infections, the media reported on Monday.

According to the South China Morning Post, as China eased its zero-Covid policy, the country doubled down on vaccination drives but the vaccination rate for the elderly is worryingly low.

The vaccination figure fell to "just 42.4 per cent for those aged 80 and over", the report mentioned.

The elderly, most of whom have other ailments, are most concerned about the effectiveness and safety of the vaccines.

Vaccination seemed less urgent for many elderly people, especially those in the country's vast hinterland, and they lacked the motivation to get jabs.

"Some villagers complained of bad coughs, headaches and sore arms after being forced to accept their first shot, and after browsing alarmist posts about vaccine risks on social media platforms were more reluctant to get jabbed again," the report mentioned.

China has now rolled out a second Covid booster drive for high-risk groups including those aged 60 and over or with weak immune systems.

Chinese officials estimate about 250 million people (18 per cent of the population) were infected with Covid-19 in the first 20 days of December, as Beijing abruptly dismantled restrictions that had contained the disease for almost three years.

--IANS

na/ksk/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusChinaCoronavirus Vaccine

First Published: Dec 26 2022 | 12:32 PM IST

Next Story